Suppr超能文献

脑胶质瘤监测的 PET-MRI 整合:灌注-代谢不匹配率及其与分子谱分析的相关性。

Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.

机构信息

1 University of California-San Francisco School of Medicine, San Francisco, CA.

2 Department of Radiology, Division of Neuroradiology, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 E 68th St, Starr Pavilion, Box 141, New York, NY 10065.

出版信息

AJR Am J Roentgenol. 2019 Apr;212(4):883-891. doi: 10.2214/AJR.18.20531. Epub 2019 Feb 19.

Abstract

OBJECTIVE

Both F-FDG PET and perfusion MRI are commonly used techniques for posttreatment glioma surveillance. Using integrated PET-MRI, we assessed the rate of discordance between simultaneously acquired FDG PET images and dynamic contrast-enhanced (DCE) perfusion MR images and determined whether tumor genetics predicts discordance.

MATERIALS AND METHODS

Forty-one consecutive patients with high-grade gliomas (20 with grade IV gliomas and 21 with grade III gliomas) underwent a standardized tumor protocol performed using an integrated 3-T PET-MRI scanner. Quantitative measures of standardized uptake value, plasma volume, and permeability were obtained from segmented whole-tumor volumes of interest and targeted ROIs. ROC curve analysis and the Youden index were used to identify optimal cutoffs for FDG PET and DCE-MRI. Two-by-two contingency tables and percent agreement were used to assess accuracy and concordance. Twenty-six patients (63%) from the cohort underwent next-generation sequencing for tumor genetics.

RESULTS

The best-performing FDG PET and DCE-MRI cutoffs achieved sensitivities of 94% and 91%, respectively; specificities of 56% and 89%, respectively; and accuracies of 80% and 83%, respectively. FDG PET and DCE-MRI findings were discordant for 11 patients (27%), with DCE-MRI findings correct for six of these patients (55%). Tumor grade, tumor volume, bevacizumab exposure, and time since radiation predicted discordance between FDG PET and DCE-MRI findings, with an ROC AUC value of 0.78. Isocitrate dehydrogenase gene and receptor tyrosine kinase gene pathway mutations increased the ROC AUC value to 0.83.

CONCLUSION

FDG PET and DCE-MRI show comparable accuracy and sensitivity in identifying tumor progression. These modalities were shown to have discordant findings for more than a quarter of the patients assessed. Tumor genetics may contribute to perfusion-metabolism discordance, warranting further investigation.

摘要

目的

正电子发射断层扫描(PET)和灌注磁共振成像(MRI)均常用于胶质瘤治疗后监测。本研究采用一体化 PET-MRI,评估同时获取的 18F-氟代脱氧葡萄糖(FDG)PET 图像与动态对比增强(DCE)灌注 MRI 图像之间的不相符率,并确定肿瘤遗传学是否可以预测不相符率。

材料与方法

41 例高级别胶质瘤患者(20 例 4 级胶质瘤和 21 例 3 级胶质瘤)采用一体化 3T PET-MRI 扫描仪进行标准化肿瘤方案检查。从全肿瘤感兴趣区和靶向 ROI 中获得标准化摄取值、血浆容积和通透性的定量测量值。采用 ROC 曲线分析和 Youden 指数确定 FDG PET 和 DCE-MRI 的最佳截断值。采用四格表和百分比一致性评估准确性和一致性。队列中有 26 例患者(63%)接受了肿瘤遗传学的下一代测序。

结果

最佳的 FDG PET 和 DCE-MRI 截断值的灵敏度分别为 94%和 91%,特异度分别为 56%和 89%,准确性分别为 80%和 83%。11 例患者(27%)的 FDG PET 和 DCE-MRI 检查结果不一致,其中 6 例(55%)DCE-MRI 检查结果正确。肿瘤分级、肿瘤体积、贝伐单抗暴露和放疗后时间可预测 FDG PET 和 DCE-MRI 检查结果的不相符,ROC 曲线 AUC 值为 0.78。异柠檬酸脱氢酶基因突变和受体酪氨酸激酶基因突变增加了 ROC AUC 值至 0.83。

结论

FDG PET 和 DCE-MRI 在识别肿瘤进展方面具有相当的准确性和灵敏度。这两种方法在评估的患者中,有超过四分之一的患者结果不一致。肿瘤遗传学可能导致灌注代谢不相符,需要进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验